Oversættelse af "behandlede data" til engelsk sprog:
Ordbog Dansk-Engelsk
Eksempler (Eksterne kilder, ikke gennemgået)
| Flere end 1 ud af 10 behandlede patienter 1 til 10 ud af 100 behandlede patienter 1 til 10 ud af 1. 000 behandlede patienter 1 til 10 ud af 10. 000 behandlede patienter Mindre end 1 ud af 10. 000 behandlede patienter Frekvens kan ikke bestemmes ud fra tilgængelige data | affects more than 1 user in 10 affects 1 to 10 users in 100 affects 1 to 10 users in 1,000 affects 1 to 10 users in 10,000 affects less than 1 user in 10,000 frequency cannot be estimated from available data |
| Forekommer hos op til 9 ud af 100 behandlede Forekommer hos op til 9 ud af 1. 000 behandlede Kan ikke estimeres ud fra forhåndenværende data | May occur in more than one person in every 10 people Occurs in up to nine people in every 100 people Occurs in up to nine people in every 1000 people Cannot be estimated from the available data |
| Behandlede | Enoxaparin |
| 65 duloxetin behandlede patienter mod 40 placebo behandlede. | At least 30 reported pain reduction was recorded in approximately 65 of duloxetine treated patients versus 40 for placebo. |
| Behandlede filer | Processed files |
| Behandlede opgaver | Processed tasks |
| Behandlede reference | Effect Hazard Confidence |
| I den åbne indkøringsfase blev patienterne stratificeret i to grupper MTX behandlede (methotrexat behandlede) og ikke MTX behandlede. | In the open label lead in phase (OL LI) patients were stratified into two groups, MTX (methotrexate) treated or non MTX treated. |
| I den åbne indkøringsfase blev patienterne stratificeret i to grupper MTX behandlede (methotrexat behandlede) og ikke MTX behandlede. | In the open label lead in phase (OL LI) patients were stratified into two groups, MTX (methotrexate) treated or non MTX treated. |
| Fjern behandlede elementer | Remove processed items |
| Tidligere behandlede patienter | Therapy experienced patients |
| Tidligere behandlede patienter | 30 Therapy experienced patients |
| af behandlede hunde | of treated dogs |
| Meget almindelig (forekommer hos flere end 1 ud af 10 behandlede) Almindelig (forekommer hos mellem 1og 10 ud af 100 behandlede) Ikke almindelig (forekommer hos mellem 1 og 10 ud af 1. 000 behandlede) Sjælden (forekommer hos mellem 1 og 10 ud af 10. 000 behandlede) Meget sjælden (forekommer hos færre end 1 ud af 10. 000 behandlede) Ikke kendt (kan ikke bestemmes ud fra tilgængelige data) | Very common (affects more than 1 user in 10) Common (affects 1 to 10 users in 100) Uncommon (affects 1 to 10 users in 1,000) Rare (affects 1 to 10 users in 10,000) Very rare (affects less than 1 user in 10,000) Not known (frequency cannot be estimated from the available data). |
| Imidlertid viser data fra feltforsøg, at hyppigheden af pseudodrægtighed hos behandlede tæver ikke er større end i kontrol tæver (ubehandlede). | However, based on field trial data, the incidence of pseudopregnancy in treated bitches is not greater than in control (untreated) bitches. |
| Forsøgene omfattede 958 duloxetin behandlede patienter og 955 placebo behandlede patienter. | The data analysis of four 12 week, placebo controlled clinical trials in patients with SUI, including 958 duloxetine treated and 955 placebo treated patients, showed that the onset of the reported adverse events typically occurred in the first week of therapy. |
| HbA1C var stabilt hos både duloxetin behandlede og placebo behandlede patienter. | HbA1c was stable in both duloxetine treated and placebo treated patients. |
| HbA1C var stabilt hos både duloxetin behandlede og placebo behandlede patienter. | In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain, small but statistically significant increases in fasting blood glucose were observed in duloxetine treated patients HbA1c was stable in both duloxetine treated and placebo treated patients. |
| HbA1C var stabilt hos både duloxetin behandlede og placebo behandlede patienter. | In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain, small but statistically significant increases in fasting blood glucose were observed in duloxetine treated patients. |
| Undgå direkte kontakt med behandlede dyr indtil det behandlede hudområde er tørt. | Avoid direct contact with treated animals until the application area is dry. |
| Han behandlede mig dårligt. | He treated me badly. |
| 13 Tidligere behandlede patienter | Therapy experienced patients |
| Undgå direkte kontakt med det behandlede dyr før det behandlede hudområde er tørt. | After application do not stroke or groom animals until the application site is dry. |
| Undgå direkte kontakt med det behandlede dyr før det behandlede hudområde er tørt. | Avoid direct contact with treated animals until the application area is dry. |
| Undgå direkte kontakt med det behandlede dyr, før det behandlede hudområde er tørt. | Avoid direct contact with treated animals until the application area is dry. |
| Hyppigheden af bivirkningerne, der er anført nedenfor, er defineret som følgende meget almindelig (påvirker mere end 1 ud af 10 behandlede) almindelig (påvirker 1 til 10 ud af 100 behandlede) ikke almindelig (påvirker 1 til 10 ud af 1. 000 behandlede) sjælden (påvirker 1 til 10 ud af 10. 000 behandlede) meget sjælden (påvirker mindre end 1 ud af 10. 000 behandlede) ikke kendt (hyppigheden kan ikke estimeres ud fra forhåndenværende data). | The frequency of possible side effects listed below is defined using the following convention very common (affects more than 1 user in 10) common (affects 1 to 10 users in 100) uncommon (affects 1 to 10 users in 1,000) rare (affects 1 to 10 users in 10,000) very rare (affects less than 1 user in 10,000) not known (frequency cannot be estimated from the available data). |
| Meget almindelige bivirkninger (forekommer hos flere end 1 ud af 10 behandlede) Almindelige bivirkninger (forekommer hos mellem 1 og 10 ud af 100 behandlede) Ikke almindelige bivirkninger (forekommer hos mellem 1 og 10 ud af 1. 000 behandlede) Sjældne bivirkninger (forekommer hos mellem 1 og 10 ud af 10. 000 behandlede) Meget sjældne bivirkninger (forekommer hos færre end 1 ud af 10. 000 behandlede) Ukendte bivirkninger (hyppigheden kan ikke bestemmes ud fra tilgængelig data). | Very common (affects more than 1 user in 10) Common (affects 1 to 10 users in 100) Uncommon (affects 1 to 10 users in 1,000) Rare (affects 1 to 10 users in 10,000) Very rare (affects less than 1 user in 10,000) Not known (frequency cannot be estimated from the available data). |
| Hun behandlede blomsterne med sprøjtemidler. | She sprayed pesticide on the flowers. |
| 15 af de behandlede patienter. | Hypersensitivity Current data suggest that, during the first year of therapy, IgG antibodies to imiglucerase are formed in approximately 15 of the treated patients. |
| 15 af de behandlede patienter. | Hypersensitivity Current data suggest that, during the first year of therapy, IgG antibodies to imigluceraseare formed in approximately 15 of the treated patients. |
| Bivirkninger hos tidligere behandlede patienter | Undesirable effects in previously treated patients |
| Tidligere behandlede B CLL patienter | Previously treated B CLL Patients |
| Behandlede patienter Blod og lymfesystem | Number of patients treated |
| Behandlede patienter, N Antal alvorlige | Treated patients N Number of MBE N( ) RE MODEL (knee) |
| som stammer fra behandlede dyr | programmes for the diagnosis, control and elimination of animal diseases, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals |
Relaterede søgninger: Af De Behandlede - Jeg Behandlede Dig Som - Den Måde De Behandlede - Behandlede Dem Som - Han Behandlede Dig - Lægen Der Behandlede - Behandlede Mig Som Lort - Vi Behandlede Dig - Jeg Behandlede Hende Som - Blegede Eller Behandlede -
